| Attribute |
Value |
| 52 Week Change |
0.021477103 |
| Address1 |
1 West First Avenue |
| All Time High |
377.54 |
| All Time Low |
2.46875 |
| Ask |
0.0 |
| Ask Size |
440 |
| Audit Risk |
2 |
| Average Analyst Rating |
1.6 - Buy |
| Average Daily Volume10 Day |
1,713,560 |
| Average Daily Volume3 Month |
1,826,680 |
| Average Volume |
1,826,680 |
| Average Volume10Days |
1,713,560 |
| Beta |
0.581 |
| Bid |
0.0 |
| Bid Size |
200 |
| Board Risk |
2 |
| Book Value |
17.463 |
| City |
Conshohocken |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
1 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
306.13 |
| Current Ratio |
0.947 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
308.835 |
| Day Low |
303.3 |
| Debt To Equity |
420.985 |
| Display Name |
Cencora |
| Dividend Date |
1,780,272,000 |
| Dividend Rate |
2.4 |
| Dividend Yield |
0.78 |
| Earnings Call Timestamp End |
1,785,960,000 |
| Earnings Call Timestamp Start |
1,785,960,000 |
| Earnings Growth |
1.283 |
| Earnings Quarterly Growth |
1.286 |
| Earnings Timestamp |
1,785,933,000 |
| Earnings Timestamp End |
1,785,933,000 |
| Earnings Timestamp Start |
1,785,933,000 |
| Ebitda |
5,300,438,016 |
| Ebitda Margins |
0.01613 |
| Enterprise To Ebitda |
13.709 |
| Enterprise To Revenue |
0.221 |
| Enterprise Value |
72,663,949,312 |
| Eps Current Year |
17.77289 |
| Eps Forward |
19.80706 |
| Eps Trailing Twelve Months |
13.04 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,778,803,200 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
278.6396 |
| Fifty Day Average Change |
27.490417 |
| Fifty Day Average Change Percent |
0.09865941 |
| Fifty Two Week Change Percent |
2.1477103 |
| Fifty Two Week High |
377.54 |
| Fifty Two Week High Change |
-71.41 |
| Fifty Two Week High Change Percent |
-0.18914552 |
| Fifty Two Week Low |
244.82 |
| Fifty Two Week Low Change |
61.309998 |
| Fifty Two Week Low Change Percent |
0.25042886 |
| Fifty Two Week Range |
244.82 - 377.54 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
797,002,200,000 |
| Five Year Avg Dividend Yield |
1.01 |
| Float Shares |
184,002,231 |
| Forward Eps |
19.80706 |
| Forward P E |
15.4556 |
| Free Cashflow |
-318,246,112 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
47,000 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.03796 |
| Gross Profits |
12,477,555,712 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0423 |
| Held Percent Institutions |
0.99007004 |
| Implied Shares Outstanding |
194,561,060 |
| Industry |
Medical Distribution |
| Industry Disp |
Medical Distribution |
| Industry Key |
medical-distribution |
| Ir Website |
http://www.amerisourcebergen.com/investor/phoenix.zhtml?c=61181&p=irol-irhome |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,778,803,200 |
| Last Dividend Value |
0.6 |
| Last Fiscal Year End |
1,759,190,400 |
| Last Split Date |
1,245,110,400 |
| Last Split Factor |
2:1 |
| Long Business Summary |
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania. |
| Long Name |
Cencora, Inc. |
| Market |
us_market |
| Market Cap |
59,560,976,384 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_24809 |
| Most Recent Quarter |
1,774,915,200 |
| Name Change Date |
2,026-07-14 |
| Net Income To Common |
2,548,677,120 |
| Next Fiscal Year End |
1,790,726,400 |
| Non Diluted Market Cap |
59,560,977,297 |
| Number Of Analyst Opinions |
12 |
| Open |
305.0 |
| Operating Cashflow |
2,276,133,888 |
| Operating Margins |
0.01716 |
| Overall Risk |
2 |
| Payout Ratio |
0.1762 |
| Peg Ratio |
0.64 |
| Phone |
610 727 7000 |
| Pre Market Change |
-0.36001587 |
| Pre Market Change Percent |
-0.11760228 |
| Pre Market Price |
305.77 |
| Pre Market Time |
1,784,027,102 |
| Prev Name |
AmerisourceBergen Corporation |
| Previous Close |
303.44 |
| Price Eps Current Year |
17.224548 |
| Price Hint |
2 |
| Price To Book |
17.530209 |
| Price To Sales Trailing12 Months |
0.18121265 |
| Profit Margins |
0.00775 |
| Quick Ratio |
0.482 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
buy |
| Recommendation Mean |
1.57143 |
| Region |
US |
| Regular Market Change |
2.69 |
| Regular Market Change Percent |
0.886502 |
| Regular Market Day High |
308.835 |
| Regular Market Day Low |
303.3 |
| Regular Market Day Range |
303.3 - 308.835 |
| Regular Market Open |
305.0 |
| Regular Market Previous Close |
303.44 |
| Regular Market Price |
306.13 |
| Regular Market Time |
1,783,972,803 |
| Regular Market Volume |
853,593 |
| Return On Assets |
0.03486 |
| Return On Equity |
1.0713401 |
| Revenue Growth |
0.038 |
| Revenue Per Share |
1,693.166 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
7 |
| Shares Outstanding |
194,561,060 |
| Shares Percent Shares Out |
0.028299998 |
| Shares Short |
5,498,838 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
5,526,396 |
| Short Name |
Cencora, Inc. |
| Short Percent Of Float |
0.0321 |
| Short Ratio |
3.51 |
| Source Interval |
15 |
| State |
PA |
| Symbol |
COR |
| Target High Price |
412.0 |
| Target Low Price |
285.0 |
| Target Mean Price |
353.5 |
| Target Median Price |
350.0 |
| Total Cash |
2,176,496,128 |
| Total Cash Per Share |
11.187 |
| Total Debt |
15,092,111,360 |
| Total Revenue |
328,680,013,824 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
2.3 |
| Trailing Annual Dividend Yield |
0.007579752 |
| Trailing Eps |
13.04 |
| Trailing P E |
23.476227 |
| Trailing Peg Ratio |
0.6481 |
| Triggerable |
1 |
| Two Hundred Day Average |
324.63806 |
| Two Hundred Day Average Change |
-18.508057 |
| Two Hundred Day Average Change Percent |
-0.05701136 |
| Type Disp |
Equity |
| Volume |
853,593 |
| Website |
https://www.cencora.com |
| Zip |
19,428-1800 |